2 completed, 1 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Stage IIIA Skin Melanoma: new trials by email Literature Review of Stage IIIA Skin Melanoma trials Research Report on Stage IIIA Skin Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy Nivolumab, Rituximab and Hyaluronidase Human, Ipilimumab - Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV | Phase 2 | Completed | Emory University | 15 | 2019-06-05 | 2026-10-02 |
| Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma Aldesleukin, Laboratory Biomarker Analysis, Pembrolizumab - Metastatic Melanoma, Stage III Mucosal Melanoma of the Head and Neck | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 10 | 2017-03-21 | 2023-08-03 |
| Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification Imatinib Mesylate, Laboratory Biomarker Analysis, Pembrolizumab - Stage IIIA Skin Melanoma, Stage IIIB Skin Melanoma | Phase 1 / Phase 2 | Withdrawn | Joanne Jeter | 2016-11-04 | 2018-04-05 | |
| Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma Epacadostat, MELITAC 12.1 Peptide Vaccine - Mucosal Melanoma, Recurrent Melanoma | Phase 2 | Completed | Fred Hutchinson Cancer Center | 11 | 2013-09-13 | 2018-06-08 |
Melanoma (4) · Uveal Melanoma (1)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Nerve Tissue (4) · Neuroectodermal Tumors (4) · Neuroendocrine Tumors (4) · Nevi and Melanomas (4) · Skin Diseases (4) · Skin Neoplasms (4) · Skin and Connective Tissue Diseases (4) · Eye Diseases (1) · Eye Neoplasms (1) · Uveal Diseases (1) · Uveal Neoplasms (1)
pembrolizumab (2) · Imatinib Mesylate (1) · Ipilimumab (1) · Nivolumab (1) · Rituximab (1) · aldesleukin (1) · epacadostat (1)
Emory University (1) · Fred Hutchinson Cancer Center (1) · Joanne Jeter (1) · Rutgers, The State University of New Jersey (1)
United States (3)
Adam Berger, MD (1) · Craig Slingluff (1) · Joanne Jeter, MD (1) · Kavita Dhodapkar, MD (1)
P30CA016058 (1), P30CA072720 (1), U01CA154967 (1)